Literature DB >> 11327254

Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.

E Casado1, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet, X Tena.   

Abstract

OBJECTIVE: To determine the relationship between the CD4+ lymphocyte count and musculoskeletal manifestations of human immunodeficiency virus (HIV) infection.
METHODS: All patients from 1991 to 1998 who were positive for HIV with osteoarticular manifestations were reviewed retrospectively. HIV positivity was confirmed by ELISA and Western blot. CD4 count was performed by flow cytometry.
RESULTS: We studied 74 patients with osteoarticular manifestations. The study group comprised 61 men (82.4%) and 13 women (17.5%) with a mean age of 34.2 years (range 17-62). Fifty-two patients were iv drug users (70.3%). Septic arthritis was present in 20 cases (23.0%), soft tissue infections in 9 cases (12.2%), spondyloarthropathies in 6 cases (8.1%), lymphomas in 9 cases (12.2%), osteomyelitis in 6 (8.1%), and 24 miscellaneous cases (32.4%). The mean CD4 count was as follows: septic arthritis 164.7 cells/mm3, soft tissue involvement 127.1 cells/mm3, spondyloarthropathies 245.8 cells/mm3, lymphoma 132.8 cells/mm3, and osteomyelitis 233.6 cells/mm3.
CONCLUSION: Osteoarticular manifestations in the setting of HIV infection tend to be predominantly infectious. S. aureus is the microorganism most frequently involved. Ostearticular infections always appeared when the CD4 count was < 200 and pyomyositis and lymphoma appeared when CD4 was < 150. CD4 counts may be useful predictors to determine the type of musculoskeletal manifestation.

Entities:  

Mesh:

Year:  2001        PMID: 11327254

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

Review 1.  Rheumatic manifestations of human immunodeficiency virus.

Authors:  Alan M Solinger
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

Review 2.  Tropical pyomyositis (myositis tropicans): current perspective.

Authors:  S Chauhan; S Jain; S Varma; S S Chauhan
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

3.  Rheumatic manifestations among HIV positive adults attending the Infectious Disease Clinic at Mulago Hospital.

Authors:  M Kaddu-Mukasa; E Ssekasanvu; E Ddumba; D Thomas; E T Katabira
Journal:  Afr Health Sci       Date:  2011-03       Impact factor: 0.927

4.  HIV infection and shoulder pain: a challenging case.

Authors:  Ayçe Atalay; Oya Ozdemir; Gulay Sain Guven; Osman Başgöze
Journal:  Rheumatol Int       Date:  2005-08-28       Impact factor: 2.631

Review 5.  Streptococcus anginosus (Streptococcus milleri Group) Pyomyositis in a 50-Year-Old Man with Acquired Immunodeficiency Syndrome: Case Report and Review of Literature.

Authors:  M Yassin; G K Yadavalli; N Alvarado; R A Bonomo
Journal:  Infection       Date:  2009-11-10       Impact factor: 3.553

6.  [Bacterial osteitis. Special considerations in immunocompromised patients].

Authors:  C Niedhart; O Miltner; K-W Zilkens; F U Niethard
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

7.  Severe pyomyositis caused by Panton-Valentine leucocidin-positive methicillin-sensitive Staphylococcus aureus complicating a pilonidal cyst.

Authors:  Udo Lorenz; Marianne Abele-Horn; Dieter Bussen; Arnulf Thiede
Journal:  Langenbecks Arch Surg       Date:  2007-07-28       Impact factor: 3.445

Review 8.  Musculoskeletal disorders associated with HIV infection and AIDS. Part I: infectious musculoskeletal conditions.

Authors:  Jamshid Tehranzadeh; Ramon R Ter-Oganesyan; Lynne S Steinbach
Journal:  Skeletal Radiol       Date:  2004-03-18       Impact factor: 2.199

Review 9.  Assessment and management of musculoskeletal disorders among patients living with HIV.

Authors:  Karen Walker-Bone; Erin Doherty; Kaushik Sanyal; Duncan Churchill
Journal:  Rheumatology (Oxford)       Date:  2017-10-01       Impact factor: 7.580

Review 10.  Evolving spectrum of HIV-associated rheumatic syndromes.

Authors:  Christine Fox; Karen Walker-Bone
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-05-23       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.